Syneos Health_rgb_r.jpg
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
09 sept. 2021 09h00 HE | Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
09 sept. 2021 08h30 HE | Wave Life Sciences USA, Inc.
Only clinical-stage candidate for Huntington’s disease designed to selectively lower mutant HTT and spare wild-type HTT Adaptive trial design to enable faster optimization of dosing and...
CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development
08 sept. 2021 11h15 HE | CaaMTech
ISSAQUAH, Wash., Sept. 08, 2021 (GLOBE NEWSWIRE) -- CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing round, led by...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021
08 sept. 2021 08h30 HE | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
WAVE LOGO NEW COLOR SWOOSH.jpg
Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences
07 sept. 2021 08h30 HE | Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
22157.jpg
Global Cell Therapy Market Opportunity: USD 45 Billion+ By 2028
06 sept. 2021 04h23 HE | Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. In last...
H1 Launches First Solution That Brings Life Sciences Teams The Data Needed To Build More Inclusive, Successful Trials
02 sept. 2021 13h00 HE | H1
NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) --  H1, which provides the largest global healthcare platform connecting the healthcare ecosystem, announced today that it has launched H1 Trial Landscape,...
22157.jpg
United States $46 Billion Biosimilar Insulin Market Opportunity & Clinical Trials Forecasts to 2026
27 août 2021 06h13 HE | Research and Markets
Dublin, Aug. 27, 2021 (GLOBE NEWSWIRE) -- The "US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The US...
22157.jpg
Insights on the AI-based Clinical Trials Solution Provider Global Market to 2028 - by Therapeutic Application, Clinical Trial Phase, End-user and Region
26 août 2021 06h53 HE | Research and Markets
Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "AI-based Clinical Trials Solution Provider Market Size, Share & Trends Analysis Report by Therapeutic Application (Oncology, Cardiovascular...
22157.jpg
World Microbiome Landscape Clinical Trial Analytics Report 2021: Top 10 Sponsors and Top 10 Companies with Most Ongoing Microbiome Trials
24 août 2021 03h18 HE | Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "2021 Clinical Trial Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering. The number of ongoing clinical...